TRAF3功能丧失揭示了非正规的NF-κB通路作为扩散大B细胞淋巴瘤的治疗点
Michael Y Li1,2, Lauren C Chong1, Gerben Duns1
1Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC V5Z 1L3, Canada.
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中,TRAF3基因的反复删除激活非正规NF-κB通路. 准NIK,一个关键酶,显示出治疗TRAF3缺乏DLBCL的希望.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤.
- 非正规的NF-κB通路在B细胞存活和淋巴发育中起作用.
- TRAF3作为NF-κB信号的负调节器.
研究的目的:
- 在新的DLBCL中调查TRAF3的作用.
- 探索TRAF3变化与NF-κB通路激活之间的关联.
- 为了确定TRAF3缺陷DLBCL中的潜在治疗点.
主要方法:
- 在DLBCL患者样本中分析chr14q32.31-32位点删除.
- 对基因拷贝数和通路活性进行综合分析.
- 使用TRAF3基因切除的DLBCL的实验模型.
- 尼克抑制研究和细胞因子分泌分析.
- 用T细胞进行共同培养实验,以评估免疫微环境的影响.
主要成果:
- 在24/324个DLBCL病例中发现了包括TRAF3在内的chr14q32.31-32位点的重复焦点缺失.
- TRAF3拷贝数损失与NIK积累和非正规NF-κB活动增加相关.
- 在DLBCL模型中,TRAF3消去调节了NIK并增强了下游信号,导致扩散和生存.
- 尼克抑制对特拉夫3缺乏DLBCL细胞产生了差异影响,这表明存在上.
- 失去TRAF3会加剧IL-10的分泌,损害CD8+T细胞的功能,这种功能通过IL-10中和而恢复.
结论:
- 在TRAF3中发生的遗传变化与DLBCL中非正规NF-κB通路激活直接相关.
- 尼克是DLBCL的一个潜在的治疗点,其特点是TRAF3损失.
- 通过IL-10,TRAF3缺乏导致免疫抑制瘤微环境,影响抗瘤免疫力.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
134
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
134
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903


